Search Results - Gitlin, Norman

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Pattern Classification of Patients with Spontaneous Bacterial Peritonitis Using New Orthogonal Functions with Extensions to Higher Dimensions

    Pattern Classification of Patients with Spontaneous Bacterial Peritonitis Using New Orthogonal Functions with Extensions to Higher Dimensions by Hudson, Donna L., Cohen, Moses E., Gitlin, Norman

    Published 1984
    Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1‐infected patients without cirrhosis: OPTIMIST‐1, a phase 3, randomized study

    Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1‐infected patients without cirrhosis: OPTIMIST‐1, a phase 3, randomized study by Kwo, Paul, Gitlin, Norman, Nahass, Ronald, Bernstein, David, Etzkorn, Kyle, Rojter, Sergio, Schiff, Eugene, Davis, Mitchell, Ruane, Peter, Younes, Ziad, Kalmeijer, Ronald, Sinha, Rekha, Peeters, Monika, Lenz, Oliver, Fevery, Bart, De La Rosa, Guy, Scott, Jane, Witek, James

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET‐NASH Study

    Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET‐NASH Study by Barritt, A. Sidney, Watkins, Stephanie, Gitlin, Norman, Klein, Samuel, Lok, Anna S., Loomba, Rohit, Schoen, Cheryl, Reddy, K. Rajender, Trinh, Huy Ngoc, Mospan, Andrea R., Vos, Miriam B., Weiss, L. Michael, Cusi, Kenneth, Neuschwander‐Tetri, Brent A., Sanyal, Arun J.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study

    All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study by Nelson, David R, Cooper, James N, Lalezari, Jacob P, Lawitz, Eric, Pockros, Paul J, Gitlin, Norman, Freilich, Bradley F, Younes, Ziad H, Harlan, William, Ghalib, Reem, Oguchi, Godson, Thuluvath, Paul J, Ortiz-Lasanta, Grisell, Rabinovitz, Mordechai, Bernstein, David, Bennett, Michael, Hawkins, Trevor, Ravendhran, Natarajan, Sheikh, Aasim M, Varunok, Peter, Kowdley, Kris V, Hennicken, Delphine, McPhee, Fiona, Rana, Khurram, Hughes, Eric A

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: